Cefoselis - CAS 122841-10-5
Catalog number: 122841-10-5
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C19H22N8O6S2
Molecular Weight:
522.56
COA:
Inquire
Targets:
Antibacterial
Description:
Cefoselis, a new parenteral cephalosporin, was active against clinical isolates of both gram-positive and gram-negative aerobic bacteria. The activity of Cefoselis was similar to that of cefpirome and cefepime and generally superior to that of ceftazidime. Cefoselis showed potent antibacterial activity against Hemophilus influenzae and Moraxella catarrhalis.Cefoselis was highly active against MSSA and MSCNS. Cefoselis was poor in the activity against MRSA,MRCNS,PRSP and Enterococcus faecalis,and no activity for Enterococcus faecium.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
Wincef
MSDS:
Inquire
1.Effect of experimental renal failure on the pharmacodynamics of cefoselis-induced seizures in rats.
Nagata M1, Yasuhara M. Biol Pharm Bull. 2001 Sep;24(9):1049-52.
We investigated the effect of infusion rate and experimental renal failure on the pharmacodynamics of cefoselis (CFSL)-induced seizures. As an animal model of CFSL-induced seizures, male Wistar rats received an intravenous infusion of CFSL at one of three different rates (1.4-5.8 g/h/rat) until the onset of maximal seizures (which occurred after 8.0 to 36.0 min of infusion). Samples of cerebrospinal fluid (CSF), blood (for serum), and brain were obtained immediately after stopping infusion of CSFL. The serum concentration of CFSL at the onset of seizures increased with increasing infusion rate, but brain and CSF concentrations of CFSL at the onset of seizures were not affected by the infusion rate. Ureter-ligated (UL) and control rats received an intravenous infusion of CFSL at 1.4 g/h/rat until the onset of seizures. Then the same procedure as used to determine the effect of infusion rate on the concentrations of CFSL was carried out. Renal failure was associated with a significant decrease in the amount of CFSL required to induce seizures.
2.Successful Treatment of Refractory Majocchi's Granuloma with Voriconazole and Review of Published Literature.
Liu HB1, Liu F, Kong QT, Shen YN, Lv GX, Liu WD, Sang H. Mycopathologia. 2015 Oct;180(3-4):237-43. doi: 10.1007/s11046-015-9902-5. Epub 2015 Jun 5.
Majocchi's granuloma (MG) is a rare deep skin dermatophyte infection that can occur either in immunocompetent or in immunocompromised individuals. Oral itraconazole or terbinafine is considered to be the first choice of treatment. We report an immunocompetent man with deep nodular form of MG, the form which is generally found in immunosuppressed individuals. Previous treatment with either oral itraconazole or terbinafine yielded no apparent improvement. After a series of examination, the man was diagnosed as having Trichophyton rubrum-induced MG mixed with bacterial infection as evidenced by growth of Klebsiella pneumoniae in tissue bacterial culture. The patient was treated with a combination of cefoselis and levofloxacin for bacterial clearance followed by voriconazole treatment. After approximately 4 months of voriconazole treatment, the lesions completely resolved. Alternative medicine (voriconazole) can be considered in case of refractory infections during MG treatment.
3.The beta-lactam antibiotics, penicillin-G and cefoselis have different mechanisms and sites of action at GABA(A) receptors.
Sugimoto M1, Fukami S, Kayakiri H, Yamazaki S, Matsuoka N, Uchida I, Mashimo T. Br J Pharmacol. 2002 Jan;135(2):427-32.
The action of the beta-lactam antibiotics, penicillin-G (PCG) and cefoselis (CFSL) on GABA(A) receptors (GABA(A)-R) was investigated using the two-electrode voltage clamp technique and Xenopus oocyte expressed murine GABA(A)-R. Murine GABA(A)-Rs were expressed in Xenopus oocytes by injecting cRNA that encoded for each subunit (alpha1, beta2, and gamma2) and the effects of PCG and CFSL on the alpha1beta2gamma2s subunit receptors were examined using two-electrode voltage clamp. Using the alpha1beta2gamma2s GABA(A)-R, PCG and CFSL inhibited GABA-induced currents in a concentration-dependent manner, with IC(50)s of 557.1+/-125.4 and 185.0+/-26.6 microM, respectively. The inhibitory action of PCG on GABA-induced currents was non-competitive whereas that of CFSL was competitive. Mutation of tyrosine to phenylalanine at position 256 in the beta2 subunit (beta2(Y256F)), which is reported to abolish the inhibitory effect of picrotoxin, drastically reduced the potency of PCG (IC(50)=28.
4.Stability studies of cefoselis sulfate in the solid state.
Zalewski P1, Skibiński R2, Talaczyńska A3, Paczkowska M3, Garbacki P3, Cielecka-Piontek J3. J Pharm Biomed Anal. 2015 Oct 10;114:222-6. doi: 10.1016/j.jpba.2015.05.033. Epub 2015 Jun 1.
The process of degradation was studied by using an HPLC-DAD method. Two degradation products were identified with a hybrid ESI-Q-TOF mass spectrometer. The influence of temperature and relative air humidity (RH) on the stability of cefoselis sulfate was investigated. In the solid state at increased RH the degradation of cefoselis sulfate was an autocatalytic reaction of the first order with respect to substrate concentration while in dry air was first-order reaction depending on the substrate concentration. The kinetic and thermodynamic parameters of degradation were calculated.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Antibacterial Products


CAS 25999-31-9 Lasalocid

Lasalocid
(CAS: 25999-31-9)

Lasalocid, isolated from certain Streptomyces sp., is an antibacterial agent and a coccidiostat for gastrointestinal parasites in veterinary practice.

CAS 70458-92-3 Pefloxacin

Pefloxacin
(CAS: 70458-92-3)

Pefloxacin is a an antibacterial agent and prevents bacterial DNA replication by inhibiting DNA gyrase. It is a synthetic chemotherapeutic agent used to treat s...

CAS 6054-98-4 Olsalazine Sodium

Olsalazine Sodium
(CAS: 6054-98-4)

Olsalazine Sodium is an anti-inflammatory prodrug, which consists of two 5-ASA moieties linked by an azo bond. It is used in the treatment of inflammatory bowel...

CAS 26605-69-6 Sodium Indanylcarbinicillin

Sodium Indanylcarbinicillin
(CAS: 26605-69-6)

Sodium Indanylcarbinicillin, a penicillin-derived, has been used as a β-lactam antibiotic which inhibits the synthesis of peptidoglycan, a key component of the...

CAS 723-46-6 Sulfamethoxazole

Sulfamethoxazole
(CAS: 723-46-6)

Sulfamethoxazole is a sulfonamide bacteriostatic antibiotic with an IC50 of 2.7 μM.

N-Acetyl-Calicheamicin
(CAS: 108212-76-6)

N-Acetyl-Calicheamicin, a derivative of Calicheamicin, is a member of enediyne antitumor antibiotics that could be a potential cytotoxic DNA-binding agent.

CAS 144-82-1 Sulfamethizole

Sulfamethizole
(CAS: 144-82-1)

Sulfamethizole is a sulfathiazole antibacterial agent.

CAS 161715-21-5 Tebipenem

Tebipenem
(CAS: 161715-21-5)

Tebipenem(LJC-11036) is a broad spectrum orally administered antibiotic; exhibits slow tight-binding inhibition at low micromolar concentrations versus the chro...

CAS 82009-34-5 Cilastatin

Cilastatin
(CAS: 82009-34-5)

Cilastatin can prevent renal metabolism of penem and carbapenem antibiotics by specific and reversible dehydropeptidase I inhibition. It can be used as antibact...

CAS 136212-91-4 Dermaseptin

Dermaseptin
(CAS: 136212-91-4)

Dermaseptin is a 34-residue antimicrobial peptide.

CAS 76801-85-9 Azathramycin

Azathramycin
(CAS: 76801-85-9)

Azithromycin, derived from erythromycin, is a antibiotic. It binds to the 50S subunit of the bacterial ribosome, and thus inhibits translation of mRNA. It is an...

CAS 19562-30-2 Piromidic acid

Piromidic acid
(CAS: 19562-30-2)

Piromidic acid is a quinolone antibiotic to treat gram-negative bacteria infections.

CAS 38821-53-3 Cephradine

Cephradine
(CAS: 38821-53-3)

Cephradine is abroad spectrum first generation cephalosporin antibiotic.

Auriclosene
(CAS: 846056-87-9)

Auriclosene is a potent and Broad spectrum antimicrobial agent. It is highly effective in in vitro studies against multi-drug resistant bacteria including Methi...

CAS 79660-72-3 Fleroxacin

Fleroxacin
(CAS: 79660-72-3)

Fleroxacin is a bactericidal drug that inhibits bacterial DNA gyrase and topoisomerase IV. Like other quinolones and fluoroquinolones, it eradicates bacteria by...

CAS 97519-39-6 Ceftibuten

Ceftibuten
(CAS: 97519-39-6)

Ceftibuten is a third-generation cephalosporin antibiotic. It displayed high activity against Haemophilus influenzae and Branhamella catarrhalis. It is an orall...

CAS 101363-10-4 Rufloxacin

Rufloxacin
(CAS: 101363-10-4)

Rufloxacin, a quinolone derivative, is an antibiotic which could restrain the differentiation of B-cell and selectively act on DNA gyrase.

CAS 127254-12-0 Sitafloxacin

Sitafloxacin
(CAS: 127254-12-0)

Sitafloxacin, a new-generation, broad-spectrum oral fluoroquinolone that is very active against many Gram-positive, Gram-negative and anaerobic clinical isolate...

CAS 55721-31-8 Salinomycin sodium salt

Salinomycin sodium salt
(CAS: 55721-31-8)

Salinomycin sodium salt, a polyether ionophore antibiotic isolated from Streptomyces albus, is an antibacterial and coccidiostat ionophore therapeutic drug. lt ...

CAS 4697-14-7 Ticarcillin disodium

Ticarcillin disodium
(CAS: 4697-14-7)

Ticarcillin disodium a carboxypenicillin used to prevent cross-linking of peptidoglycan during cell wall synthesis, when the bacteria try to divide, causing cel...

Chemical Structure

CAS 122841-10-5 Cefoselis

Quick Inquiry

Verification code

Featured Items